#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous calcification Myelin oligodendrocyte glycoprotein antibody-associated disease Systemic lupus erythematosus Cluster headache Growth hormone deficiency Nephropathy Crigler-Najjar syndrome Retinitis pigmentosa Immune-mediated renal disorder Retinopathy proliferative Metastases to central nervous system Cutaneous T-cell lymphoma recurrent Non-Hodgkin's lymphoma Keratosis follicular Alternating hemiplegia of childhood More trials…

    Learn about Rare Diseases

    Phenylketonuria Extranodal marginal zone B-cell lymphoma (MALT type) – Basic Information Cytokine release syndrome – Life with Disease Small intestine leiomyosarcoma – Diagnostics Glomerulonephritis rapidly progressive – Trials in Disease Primary mediastinal large B-cell lymphoma – Treatment Prolymphocytic leukaemia – Diagnostics Optic glioma – Life with Disease Thrombotic thrombocytopenic purpura – Life with Disease Progressive supranuclear palsy – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nebivolol Hydrochloride Aciclovir Hydralazine Hydrochloride Metformin Embonate Berzosertib Methylprednisolone Acetate Cefixime Rosuvastatin Zinc Dexpanthenol CHONDROITIN SULFATE SODIUM Cimetidine STREPTOCOCCUS PYOGENES POLYMYXIN B SULFATE Ropivacaine Onasemnogene Abeparvovec Cefaclor Dimeticone Flecainide XENON (133XE) ALPROSTADIL More therapies…

    Learn about Your Condition

    Irritable bowel syndrome Anogenital warts Skin wrinkling Hypoparathyroidism Psychotic disorder Hydrocephalus Candida infection Tinnitus Pulmonary sarcoidosis Myxoid liposarcoma Ocular myasthenia Mantle cell lymphoma stage II Inflammation Friedreich's ataxia Peripheral ischaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effects and Safety of Ianalumab in Adults with Lupus Nephritis Who Completed Previous Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Mycophenolic Acid
    • Emtricitabine
    • Entecavir
    Czechia France Hungary Lithuania Romania Spain

  • Study on Early Use of Ivabradine for Children with Heart Failure Due to Dilated Cardiomyopathy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Cardiac failure acute
    • Dilated cardiomyopathy
    Investigated Drugs:
    • Ivabradine Hydrochloride
    Italy

  • Study on the Safety and Effectiveness of Inclisiran for Children Aged 6 to Under 12 with Familial Hypercholesterolemia

    Recruiting

    3 1 1
    Investigated Drugs:
    • Inclisiran
    Austria Belgium Czechia France Germany Greece +6

  • Study on Spesolimab for Adults with Pyoderma Gangrenosum Requiring Systemic Therapy

    Recruiting

    3 1
    Investigated Drugs:
    • Spesolimab
    Austria Belgium Finland France Germany Italy +5

  • Study of Satralizumab for Children with Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Recruiting

    3 1 1
    Investigated Drugs:
    • Satralizumab
    France Italy Poland

  • Study of Amlitelimab and BI 1015550 for Patients with Interstitial Lung Disease Due to Scleroderma

    Recruiting

    2 1
    Investigated Diseases:
    • Systemic scleroderma
    • Interstitial lung disease
    Investigated Drugs:
    • Amlitelimab
    • Bi 1015550
    Austria Belgium Denmark France Germany Italy +5
Previous Page
1 … 648 649 650 651 652 … 1,656
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!